Terms ending in 2035
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,695,144 | Dibenzazepine Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,047,075 | Pyridines and Pyrimidines and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 11,401,258 | Isoquinoline Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 11,180,502 | AZASPIRO[4.5]DECANE Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 12,403,130 | Pharmaceutical Combinations for Treating Cancer In force · Low confidence | Knoa Pharma LLC | In force | Low confidence | |
| US 10,730,866 | Indole Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,975,854 | BENZOMORPHAN ANALOGS And Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,030,021 | Spirocyclic Morphinans and Use Thereof In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 12,048,688 | Pharmaceutical Combinations for Treating Cancer In force · High confidence | Knoa Pharma LLC | In force | High confidence | |
| US 11,834,447 | Indole Derivatives and Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| 18 more term ends in 2035 · Pro | |||||
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28.
26 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.